Labcorp
About: Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
Employees: 70,000
0
Funds holding %
of 7,312 funds
0
Analysts bullish %
of 6 analysts
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
122% more first-time investments, than exits
New positions opened: 113 | Existing positions closed: 51
44% more funds holding in top 10
Funds holding in top 10: 9 [Q4 2024] → 13 (+4) [Q1 2025]
5% more funds holding
Funds holding: 908 [Q4 2024] → 953 (+45) [Q1 2025]
0% less capital invested
Capital invested by funds: $17.9B [Q4 2024] → $17.8B (-$15.3M) [Q1 2025]
6% less repeat investments, than reductions
Existing positions increased: 327 | Existing positions reduced: 347
10% less call options, than puts
Call options by funds: $41.8M | Put options by funds: $46.2M
1.41% less ownership
Funds ownership: 93.03% [Q4 2024] → 91.62% (-1.41%) [Q1 2025]
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$267
7%
upside
Avg. target
$280
12%
upside
High target
$290
16%
upside
6 analyst ratings
4 positive
67%
2 neutral
33%
0 negative
0%
Evercore ISI Group Elizabeth Anderson | 14%upside $285 | Outperform Maintained | 9 Jul 2025 |
Barclays Jack Meehan | 10%upside $275 | Equal-Weight Maintained | 25 Jun 2025 |
Morgan Stanley Ricky Goldwasser | 13%upside $283 | Overweight Maintained | 11 Jun 2025 |
Truist Securities David Macdonald | 16%upside $290 | Buy Maintained | 12 May 2025 |
Piper Sandler David Westenberg | 12%upside $280 | Neutral Maintained | 6 May 2025 |
Financial journalist opinion
Based on 5 articles about LH published over the past 30 days
Neutral
PRNewsWire
1 day ago
Labcorp Declares Quarterly Dividend
BURLINGTON, N.C. , July 10, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock.
Positive
Zacks Investment Research
4 days ago
What Makes Labcorp (LH) a New Buy Stock
Labcorp (LH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Positive
Seeking Alpha
1 week ago
Labcorp Upgraded To A Buy As Portfolio Grows And Leverage Stays Low
In my follow-up article on Labcorp, I am upgrading it to a 'Buy' this time. Macro forecasts and the firm's own portfolio growth of solutions and locations could drive more tailwinds to the top line. Leverage risk remains modest in comparison to equity and vs. key peers when considering the D/E and quick ratio.
Neutral
PRNewsWire
2 weeks ago
Labcorp to Announce Second Quarter Financial Results on July 24, 2025
BURLINGTON, N.C. , June 26, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 2025 before the market opens on Thursday, July 24, 2025.
Positive
Zacks Investment Research
3 weeks ago
Labcorp Stock Climbs 25.6% This Year: What's Driving the Surge?
LH stock surges 25.6% this year, powered by specialty testing expansion, key acquisitions and solid financials.
Positive
Zacks Investment Research
1 month ago
Should You Continue to Hold Labcorp Stock in Your Portfolio?
Labcorp Holdings Inc. LH, or Labcorp's strong focus on key areas such as oncology, women's health, autoimmune disease and neurology is poised to help it grow in the upcoming quarters. The company maintains a steady pipeline of potential deals that support its financial strategy and will enhance its organic growth.
Positive
Zacks Investment Research
1 month ago
LH Stock Rises Following the Expansion of Precision Oncology Portfolio
Labcorp expands its precision oncology lineup with new cancer tests and a global diagnostic tool.
Neutral
GlobeNewsWire
1 month ago
ASU, Labcorp, and InStride announce first-of-its-kind diagnostics industry partnership that tackles critical healthcare workforce shortage
LOS ANGELES, June 02, 2025 (GLOBE NEWSWIRE) -- InStride , a leading provider of strategic education and skilling solutions, has facilitated a unique partnership between Arizona State University's College of Health Solutions and Labcorp, a global leader of innovative and comprehensive laboratory services, to launch a Master of Science in Cytology. ASU's online graduate program addresses the severe shortage of cytotechnologists—specialists essential to cancer detection and diagnostics.
Neutral
PRNewsWire
1 month ago
Labcorp Expands Oncology Portfolio to Improve Patient Care and Advance Cancer Research
New test offerings target solid tumors and hematologic malignancies Enhanced biopharma services support accelerated clinical trials and companion diagnostic development BURLINGTON, N.C. , May 30, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the expansion of its precision oncology portfolio.
Positive
Zacks Investment Research
1 month ago
Why Is Labcorp (LH) Up 2.5% Since Last Earnings Report?
Labcorp (LH) reported earnings 30 days ago. What's next for the stock?
Charts implemented using Lightweight Charts™